|
DERIVATIVE INSTRUMENTS
|
3 Months Ended |
|---|---|
|
Mar. 31, 2012
|
|
| DERIVATIVE INSTRUMENTS [Abstract] | |
| DERIVATIVE INSTRUMENTS |
NOTE 3-DERIVATIVE INSTRUMENTS
The Company primarily uses forward currency contracts and options to reduce its exposure to foreign currency risk associated with short-term artist fee commitments. The Company also enters into forward currency contracts to minimize the risks and/or costs associated with changes in foreign currency rates on forecasted operating income and short-term intercompany loans. At March 31, 2012 and December 31, 2011, the Company had forward currency contracts and options outstanding with notional amounts of $201.1 million and $32.5 million, respectively. These instruments have not been designated as hedging instruments and any change in fair value is reported in earnings during the period of the change. The Company's foreign currency derivative activity, including the related fair values, are not material to any period presented.
Additionally, the Company has entered into certain interest rate swaps and cap agreements to limit its exposure to variable interest rates, related to portions of the Company's outstanding debt, some of which have been designated as cash flow hedges. At March 31, 2012 and December 31, 2011, the Company had interest rate swaps and cap agreements outstanding with notional amounts of $129.2 million and $131.0 million, respectively. The Company's interest rate swaps and caps activity, including the related fair values, are not material to any period presented.
As of March 31, 2012 and December 31, 2011, there is no ineffective portion or amount excluded from effectiveness testing for derivatives designated as cash flow hedging instruments.
The Company's 2.875% convertible senior notes issued in July 2007 include certain provisions which are bifurcated from the notes and accounted for as derivative instruments. At the date of issuance and as of March 31, 2012 and December 31, 2011, the fair value of these provisions was considered to be de minimis.
The Company does not enter into derivative instruments for speculation or trading purposes and does not anticipate any significant recognition of derivative activity through the income statement in the future related to the instruments currently held. See Note 4-Fair Value Measurements for further discussion and disclosure of the fair values for the Company's derivative instruments.
|